Riskpilot← Back to searchSign inGet full accessPATOGEN AS
ASActiveOrg 985525331Rasmus Rønnebergs Gate 21, 6002 ÅlesundResearch and experimental development on natural sciences and engineering · NACE 7210Est. 200356 employeeswww.patogen.no
Revenue 2024
NOK 107,8M
+2% vs 2023
EBITDA margin
5.9%
-51% vs 2023
Equity ratio
69.1%
Financial strength
Net profit 2024
NOK 3,7M
-70% vs 2023
| Revenue | NOK 107,8M | +2% |
| EBITDA | NOK 6,3M | -51% |
| Net profit | NOK 3,7M | -70% |
| Total assets | NOK 64M | -7% |
| Equity | NOK 44,2M | +9% |
| Employees | 56 | — |
Legal name
PATOGEN AS
Org number
985525331
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
24. mars 2003
Share capital
NOK 666 667
Employees
56 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Etablering og drift av diagnostisk laboratorium, forskning og utvikling, konsulenttjenester, publisering av vitenskapelige artikler nasjonalt og internasjonalt, samt alt som står i forbindelse med dette, herunder investeringer i andre selskaper og fast eiendom.
Address
Rasmus Rønnebergs Gate 21, 6002 Ålesund
Website
www.patogen.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40 491 | 47 001 | 53 727 | 58 034 | 74 656 | 86 335 | 90 795 | 87 100 | 90 954 | 93 191 | 105 983 | 107 757 |
| Staff expenses | −13 560 | −17 686 | −22 880 | −24 459 | −29 536 | −35 493 | −42 099 | −40 295 | −51 749 | −37 466 | −46 223 | −53 398 |
| EBITDA | 10 607 | 10 245 | 9 714 | 12 560 | 15 546 | 16 019 | 14 004 | 11 902 | −1 150 | 14 919 | 12 920 | 6 347 |
| Depreciation & amort. | −903 | −1 461 | −2 049 | −3 277 | −3 977 | −8 346 | −13 194 | −6 744 | −6 701 | −6 792 | −3 061 | −2 683 |
| EBIT | 9 704 | 8 784 | 7 665 | 9 283 | 11 569 | 7 673 | 810 | 5 158 | −7 852 | 8 127 | 9 859 | 3 664 |
| Net financials | 322 | 356 | 219 | 18 | −106 | 1 534 | 1 601 | 1 687 | 1 616 | 5 | 1 507 | 1 173 |
| Profit before tax | 10 026 | 9 140 | 7 885 | 9 300 | 11 463 | 9 208 | 2 411 | 6 845 | −6 235 | 8 132 | 11 366 | 4 836 |
| Tax | 2 589 | 2 083 | 1 845 | 1 839 | 2 192 | 1 248 | −204 | 887 | −1 885 | 1 631 | −742 | 1 171 |
| Net profit | 7 437 | 7 057 | 6 040 | 7 462 | 9 271 | 7 960 | 2 615 | 5 958 | −4 350 | 6 501 | 12 108 | 3 665 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 33 106 | 41 581 | 28 154 | 29 607 | 49 354 | 65 734 | 64 759 | 64 929 | 65 712 | 66 099 | 68 716 | 64 023 |
| Equity | 24 076 | 31 133 | 12 173 | 19 413 | 28 469 | 36 185 | 38 800 | 38 221 | 40 363 | 46 864 | 40 552 | 44 218 |
| Long-term debt | 0 | 0 | 0 | 0 | 6 087 | 8 205 | 5 795 | 4 685 | 7 281 | 0 | 0 | 0 |
| Short-term debt | 9 031 | 10 448 | 15 981 | 10 195 | 14 798 | 21 344 | 20 164 | 22 023 | 18 067 | 19 235 | 28 164 | 19 805 |
| Total debt | 9 031 | 10 448 | 15 981 | 10 195 | 20 885 | 29 549 | 25 959 | 26 708 | 25 348 | 19 235 | 28 164 | 19 805 |
EBITDA margin
5.9%
This company
15.8%
Market median
-63% vs market
20132024
Equity ratio
69.1%
This company
38.2%
Market median
+81% vs market
20132024
Return on equity
8.3%
This company
18.4%
Market median
-55% vs market
20132024
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20132024
Asset turnover
1.68×
This company
1.12×
Market median
+50% vs market
20132024
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JU Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
NS Deputy Member | Deputy Member | 2022 | — | — |
KS Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
ET Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
LK Deputy Member | Deputy Member | 2023 | — | — |
CP Deputy Member | Deputy Member | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Dr Furst Medisinsk Laboratorium As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ferd Lab Invest As
PATOGEN AS Board members of PATOGEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørn Ulheim | Chief Executive Officer | 0 companies |
| Natalie Salen | Deputy Member | 0 companies |
| Kristoffer Stenstad | Chief Executive Officer | 0 companies |
| Ernst Thorstein Medhus | Chief Executive Officer | 0 companies |
| Linda Kristin Stavset | Deputy Member | 0 companies |
| Caroline Pedersen | Deputy Member | 0 companies |
| Sindre Svendsen Østgård | Board of Directors | 0 companies |
| Marit Solberg | Board of Directors | 0 companies |
| Bård Skjelstad | Board of Directors | 0 companies |
| Håvard Selby Ebbestad | Chairman | 0 companies |
| Morten Lund | Board of Directors | 0 companies |
| Torstein Rikter-Svendsen | Board of Directors | 0 companies |
| Øyvind Tørlen | Board of Directors | 0 companies |
| Henrik Brenna Tenfjord | Board of Directors | 0 companies |
| Ingvill Beathe Hopen | Board of Directors | 0 companies |
| Martin Huun-Røed | Board of Directors | 0 companies |
| Helge Karstein Moen | Chairman | 0 companies |
| Vidar Vegsundvåg | Board of Directors | 0 companies |